Healthcare Triangle is trading 13.29% down in pre-market at $1.50 after its August 13, 2026 Q2 earnings release, with the decline suggesting company-specific post-earnings selling despite strong growth.
- Revenue rose 158% year over year to $9.19 million; gross profit increased 322% to $2.07 million.
- Gross margin expanded to 22.5%, while broader pre-market indexes were mixed.